Overview
Paul Busse is a Radiologist and a Radiation Oncologist in Danvers, Massachusetts. Dr. Busse is rated as an Experienced provider by MediFind in the treatment of Sinus Cancer. His top areas of expertise are Laryngeal Cancer, Nasopharyngeal Carcinoma, Epithelial-Myoepithelial Carcinoma, Ganglioneuroma, and Gastrostomy. Dr. Busse is currently accepting new patients.
His clinical research consists of co-authoring 35 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Sinus Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
102 Endicott St, Mgh North Shore Medical, Danvers, MA 01923
55 Fruit St, Boston, MA 02114
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Massachusetts General Physicians Organization Inc
Annie Chan is a Radiation Oncologist in Boston, Massachusetts. Dr. Chan is rated as a Distinguished provider by MediFind in the treatment of Sinus Cancer. Her top areas of expertise are Teratocarcinosarcoma, Olfactory Neuroblastoma, Sinus Cancer, and Laryngeal Cancer. Dr. Chan is currently accepting new patients.
Brigham And Women's Hospital, Department Of Radiation Oncology
Roy Tishler is a Radiation Oncologist in Boston, Massachusetts. Dr. Tishler is rated as a Distinguished provider by MediFind in the treatment of Sinus Cancer. His top areas of expertise are Merkel Cell Carcinoma, Olfactory Neuroblastoma, Teratocarcinosarcoma, Renal Oncocytoma, and Gastrostomy.
Brigham And Women's Hospital, Department Of Radiation Oncology
"Dr. Margalit is an Associate Professor of Radiation Oncology at Harvard Medical School and a member of the Head and Neck Oncology Program and the Center for Cutaneous Oncology, specializing in the treatment of tumors of the head and neck, and skin. Dr. Margalit received her medical degree from Harvard Medical School and completed her residency in radiation oncology at the Harvard Radiation Oncology Program. She completed a post-doctoral fellowship in Cancer Epidemiology and Master of Public Health in Clinical Epidemiology at the Harvard School of Public Health.Dr. Margalit teaches and mentors students from Harvard Medical School and Residents of the Harvard Radiation Oncology Program. She is an active participant on national committees of the American Society for Radiation Oncology (ASTRO), American Board of Radiology (ABR), and American Society for Clinical Oncology (ASCO). She is a senior editor for the International Journal of Radiation Oncology ● Biology ● Physics and serves as the Chair of the multi-disciplinary American Radium Society Appropriate Use Criteria Committee for Head and Neck Cancer. Dr. Margalit’s research focuses on integrating new technologies and targeted therapies to improve cure rates while minimizing side effects of cancer treatment.She is the recipient of multiple awards including the inaugural Brigham and Women's Hospital/Dana-Farber Department of Radiation Oncology Outstanding Clinician Award that recognizes ""expert patient care, demonstrates compassion and respect, and pursues excellence with integrity.""". Dr. Margalit is rated as a Distinguished provider by MediFind in the treatment of Sinus Cancer. Her top areas of expertise are Merkel Cell Carcinoma, Adenoid Cystic Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), and Melanoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Laryngeal CancerDr. Busse isDistinguished. Learn about Laryngeal Cancer.
- Nasopharyngeal CarcinomaDr. Busse isDistinguished. Learn about Nasopharyngeal Carcinoma.
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- Anaplastic Thyroid CancerDr. Busse isAdvanced. Learn about Anaplastic Thyroid Cancer.
- Epithelial-Myoepithelial Carcinoma
- Familial Prostate CancerDr. Busse isAdvanced. Learn about Familial Prostate Cancer.
- GanglioneuromaDr. Busse isAdvanced. Learn about Ganglioneuroma.
- Oral Squamous Cell CarcinomaDr. Busse isAdvanced. Learn about Oral Squamous Cell Carcinoma.
- Experienced
- Adenoid Cystic CarcinomaDr. Busse isExperienced. Learn about Adenoid Cystic Carcinoma.
- Alveolar Soft Part SarcomaDr. Busse isExperienced. Learn about Alveolar Soft Part Sarcoma.
- AstrocytomaDr. Busse isExperienced. Learn about Astrocytoma.
- Bone TumorDr. Busse isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Busse isExperienced. Learn about Brain Tumor.
- Breast Cancer in MenDr. Busse isExperienced. Learn about Breast Cancer in Men.

